ORIENTBIO, Inc.(KR:002630)
â‚©1,136.00-17.00 (-1.47%)
KR:002630
ORIENTBIO, Inc. financials statements
â‚©1,136.00
At close:-17.00 (-1.47%)
Want to see KR:002630 full AI Analyst Report?
ORIENTBIO, Inc. (002630) Ratios
ORIENTBIO, Inc. Ratios
KR:002630's free cash flow for Q2 2026 was ₩640.39M. For the 2026 fiscal year, KR:002630's free cash flow was decreased by ₩-42.28M and operating cash flow was ₩682.67M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.82 | 11.26 | 14.02 | 12.65 | 5.17 |
| Quick Ratio | 7.39 | 10.26 | 13.15 | 11.31 | 4.85 |
| Cash Ratio | 1.04 | 1.55 | 1.45 | 1.52 | 2.20 |
| Solvency Ratio | -0.18 | -0.87 | 1.31 | -0.97 | 1.75 |
| Operating Cash Flow Ratio | 0.46 | 0.18 | 0.89 | 0.30 | 0.17 |
| Short-Term Operating Cash Flow Coverage | 3.58 | 0.00 | 0.00 | 0.00 | 0.49 |
| Net Current Asset Value | â‚© 30.89B | â‚© 34.48B | â‚© 47.09B | â‚© 39.59B | â‚© 48.73B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.03 | 0.03 | 0.01 | 0.07 |
| Debt-to-Equity Ratio | 0.03 | 0.04 | 0.04 | 0.01 | 0.09 |
| Debt-to-Capital Ratio | 0.03 | 0.04 | 0.03 | 0.01 | 0.08 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Financial Leverage Ratio | 1.19 | 1.18 | 1.14 | 1.14 | 1.26 |
| Debt Service Coverage Ratio | -2.62 | -50.03 | 275.34 | -36.00 | 0.18 |
| Interest Coverage Ratio | -34.60 | -13.97 | -11.35 | 5.76 | -8.73 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.05 |
| Interest Debt Per Share | 69.65 | 95.84 | 26.12 | 9.28 | 66.03 |
| Net Debt to EBITDA | 1.74 | 0.35 | -0.20 | 0.55 | -22.66 |
| Profitability Margins | |||||
| Gross Profit Margin | 13.30% | 24.48% | 34.22% | 34.09% | 34.30% |
| EBIT Margin | -14.93% | -44.13% | 46.36% | -42.81% | -11.14% |
| EBITDA Margin | -7.52% | -37.49% | 55.94% | -32.09% | 3.80% |
| Operating Profit Margin | -14.93% | -10.46% | -2.31% | 5.04% | -14.39% |
| Pretax Profit Margin | -15.35% | -44.88% | 45.96% | -43.69% | -12.79% |
| Net Profit Margin | -15.35% | -44.88% | 45.96% | -43.11% | 130.15% |
| Continuous Operations Profit Margin | -15.35% | -44.88% | 45.96% | -43.11% | -13.05% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 98.67% | -1017.44% |
| EBT Per EBIT | 102.82% | 428.91% | -1992.59% | -866.65% | 88.90% |
| Return on Assets (ROA) | -5.60% | -15.56% | 13.27% | -15.33% | 32.58% |
| Return on Equity (ROE) | -6.66% | -18.37% | 15.13% | -17.40% | 41.11% |
| Return on Capital Employed (ROCE) | -5.84% | -3.82% | -0.70% | 1.88% | -4.14% |
| Return on Invested Capital (ROIC) | -5.74% | -3.79% | -0.69% | 1.84% | -3.91% |
| Return on Tangible Assets | -5.60% | -15.58% | 13.29% | -15.38% | 32.73% |
| Earnings Yield | -6.66% | -7.03% | 18.43% | -16.98% | 31.18% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.50 | 2.98 | 2.05 | 3.51 | 3.94 |
| Payables Turnover | 40.72 | 38.53 | 30.21 | 37.76 | 22.46 |
| Inventory Turnover | 10.59 | 5.28 | 5.04 | 3.62 | 3.97 |
| Fixed Asset Turnover | 1.37 | 1.43 | 1.60 | 1.82 | 1.43 |
| Asset Turnover | 0.36 | 0.35 | 0.29 | 0.36 | 0.25 |
| Working Capital Turnover Ratio | 0.73 | 0.60 | 0.56 | 0.56 | 0.74 |
| Cash Conversion Cycle | 129.79 | 181.95 | 238.53 | 195.10 | 168.50 |
| Days of Sales Outstanding | 104.28 | 122.34 | 178.20 | 103.99 | 92.73 |
| Days of Inventory Outstanding | 34.47 | 69.09 | 72.41 | 100.78 | 92.01 |
| Days of Payables Outstanding | 8.96 | 9.47 | 12.08 | 9.67 | 16.25 |
| Operating Cycle | 138.75 | 191.43 | 250.61 | 204.77 | 184.75 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 87.59 | 25.38 | 31.68 | 9.78 | 19.83 |
| Free Cash Flow Per Share | 18.48 | -136.17 | 23.88 | 5.69 | 1.19 |
| Dividend Paid and CapEx Coverage Ratio | 1.27 | 0.16 | 4.06 | 2.39 | 1.06 |
| Capital Expenditure Coverage Ratio | 1.27 | 0.16 | 4.06 | 2.39 | 1.06 |
| Operating Cash Flow Coverage Ratio | 1.34 | 0.29 | 1.24 | 1.37 | 0.32 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.03 | 0.13 | 0.04 | 0.09 |
| Free Cash Flow Yield | 0.80% | -2.15% | 4.05% | 0.92% | 0.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -15.01 | -14.23 | 5.43 | -5.89 | 3.21 |
| Price-to-Sales (P/S) Ratio | 2.30 | 6.39 | 2.49 | 2.54 | 4.17 |
| Price-to-Book (P/B) Ratio | 1.00 | 2.61 | 0.82 | 1.02 | 1.32 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 125.09 | -46.53 | 24.67 | 108.49 | 780.56 |
| Price-to-Operating Cash Flow Ratio | 26.40 | 249.65 | 18.59 | 63.07 | 46.65 |
| Price-to-Earnings Growth (PEG) Ratio | 0.23 | 0.07 | -0.03 | -0.01 | -0.04 |
| Enterprise Value Multiple | -28.89 | -16.69 | 4.26 | -7.36 | 87.33 |
| Enterprise Value | 64.64B | 183.90B | 66.77B | 68.07B | 87.09B |
| EV to EBITDA | -28.89 | -16.69 | 4.26 | -7.36 | 87.33 |
| EV to Sales | 2.17 | 6.26 | 2.38 | 2.36 | 3.31 |
| EV to Free Cash Flow | 117.98 | -45.56 | 23.58 | 100.95 | 619.76 |
| EV to Operating Cash Flow | 24.90 | 244.45 | 17.77 | 58.68 | 37.04 |
| Tangible Book Value Per Share | 2309.49 | 2420.46 | 716.70 | 599.78 | 697.55 |
| Shareholders’ Equity Per Share | 2312.32 | 2423.82 | 717.70 | 602.12 | 701.52 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.01 | -0.02 |
| Revenue Per Share | 1003.76 | 991.76 | 236.19 | 243.06 | 221.59 |
| Net Income Per Share | -154.06 | -445.14 | 108.55 | -104.78 | 288.39 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | -10.17 |
| Interest Burden | 1.03 | 1.02 | 0.99 | 1.02 | 1.15 |
| Research & Development to Revenue | 0.00 | 0.03 | 0.07 | 0.06 | 0.10 |
| SG&A to Revenue | 0.11 | 0.13 | 0.14 | 0.10 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.57 | -0.06 | 0.29 | -0.09 | 0.07 |
Currency in KRW

